Researchers develop light-activated Parkinson’s drug

News

Author: Simge Eva DoganPublished: 18 July 2018

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

light-activated

A new light-activated drug for treating Parkinson’s has been developed by a research team led by the University of Barcelona, Spain.

The drug – named MRS7145 – is placed within a brain implant and then activated by shining a light on it.

The effect of the newly developed drug was tested on live mice to see if it could improve their motor function. The results – published in ‘Journal of Controlled Release’ – showed that MRS7145 reduced tremors and seizures and improved the mice’s ability to walk.

Professor Francisco Ciruela, researcher at the Faculty of Medicine and Health Sciences of the University of Barcelona, Spain, said he envisaged the drug being administered by smart phones, with “the doctor (controlling) in a precise manner the release of the most efficient dose of the active drug in the place of action”.

For more information on Parkinson’s research please visit Parkinson’s Europe website.

Go Back

Share this story

Comments


Related articles


red-deer-stag-roars-during-a-rut-in-mating-season

Perspectives

6 world-class wildlife shots by a photographer with Parkinson’s

Wildlife photographer with Parkinson’s shares his favourite shots

READ MORE
Bill Bucklew

Interviews

Bill Bucklew on walking 2,500 miles for Parkinson’s

Bill Bucklew tells us why he's not afraid of failure

READ MORE
Carer's Week lead image

Carers' Corner

10 shocking facts that show what it’s like to be a carer

Highlighting the issues faced by carers throughout Europe

READ MORE